ArticleCancer research2023
Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling.
Zhen Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it